Authors:
SONDAK VK
ROBERTSON JM
SUSSMAN JJ
SARAN PA
CHANG AE
LAWRENCE TS
Citation: Vk. Sondak et al., PREOPERATIVE IDOXURIDINE AND RADIATION FOR LARGE SOFT-TISSUE SARCOMAS, CLINICAL-RESULTS WITH 5-YEAR FOLLOW-UP, Annals of surgical oncology, 5(2), 1998, pp. 106-112
Authors:
DIEP DB
LAWRENCE TS
AUSIO J
HOWARD SP
BUCKLEY JT
Citation: Db. Diep et al., SECRETION AND PROPERTIES OF THE LARGE AND SMALL LOBES OF THE CHANNEL-FORMING TOXIN AEROLYSIN, Molecular microbiology, 30(2), 1998, pp. 341-352
Authors:
MCGINN CJ
TENHAKEN RK
ENSMINGER WD
WALKER S
WANG SB
LAWRENCE TS
Citation: Cj. Mcginn et al., TREATMENT OF INTRAHEPATIC CANCERS WITH RADIATION-DOSES BASED ON A NORMAL TISSUE COMPLICATION PROBABILITY MODEL, Journal of clinical oncology, 16(6), 1998, pp. 2246-2252
Authors:
BALTER JM
LAM KL
MCGINN CJ
LAWRENCE TS
TENHAKEN RK
Citation: Jm. Balter et al., IMPROVEMENT OF CT-BASED TREATMENT-PLANNING MODELS OF ABDOMINAL TARGETS USING STATIC EXHALE IMAGING, International journal of radiation oncology, biology, physics, 41(4), 1998, pp. 939-943
Authors:
LAWRENCE TS
HAYMAN J
MARTEL M
TENHAKEN RK
Citation: Ts. Lawrence et al., REGARDING PREDICTING RADIATION RESPONSE, International journal of radiation oncology, biology, physics, 41(4), 1998, pp. 972-972
Citation: Jd. Naida et al., THE EFFECT OF ACTIVATION OF WILD-TYPE P53 FUNCTION ON FLUOROPYRIMIDINE-MEDIATED RADIOSENSITIZATION, International journal of radiation oncology, biology, physics, 41(3), 1998, pp. 675-680
Authors:
MARTEL MK
EISBRUCH A
LAWRENCE TS
FRAASS BA
TENHAKEN RK
LICHTER AS
Citation: Mk. Martel et al., SPINAL-CORD DOSE FROM STANDARD HEAD AND NECK IRRADIATION - IMPLICATIONS FOR 3-DIMENSIONAL TREATMENT PLANNING, Radiotherapy and oncology, 47(2), 1998, pp. 185-189
Authors:
LAWRENCE TS
REHEMTULLA A
NG EY
WILSON M
TROSKO JE
STETSON PL
Citation: Ts. Lawrence et al., PREFERENTIAL CYTOTOXICITY OF CELLS TRANSDUCED WITH CYTOSINE DEAMINASECOMPARED TO BYSTANDER CELLS AFTER TREATMENT WITH 5-FLUCYTOSINE, Cancer research, 58(12), 1998, pp. 2588-2593
Citation: Ts. Lawrence et al., DELAYED RADIOSENSITIZATION OF HUMAN COLON-CARCINOMA CELLS AFTER A BRIEF EXPOSURE TO 2',2'-DIFLUORO-2'-DEOXYCYTIDINE (GEMCITABINE), Clinical cancer research, 3(5), 1997, pp. 777-782
Citation: Ts. Lawrence et Je. Tepper, COMBINED RADIATION-THERAPY AND CHEMOTHERAPY - 5-FU AND FUDR - INTRODUCTION, Seminars in radiation oncology, 7(4), 1997, pp. 247-248
Citation: Cj. Mcginn et Ts. Lawrence, CLINICAL-RESULTS OF THE COMBINATION OF RADIATION AND FLUOROPYRIMIDINES IN THE TREATMENT OF INTRAHEPATIC CANCER, Seminars in radiation oncology, 7(4), 1997, pp. 313-323
Authors:
ROBERTSON JM
MCGINN CJ
WALKER S
MARX MV
KESSLER ML
ENSMINGER WD
LAWRENCE TS
Citation: Jm. Robertson et al., A PHASE-I TRIAL OF HEPATIC ARTERIAL BROMODEOXYURIDINE AND CONFORMAL RADIATION-THERAPY FOR PATIENTS WITH PRIMARY HEPATOBILIARY CANCERS OR COLORECTAL LIVER METASTASES, International journal of radiation oncology, biology, physics, 39(5), 1997, pp. 1087-1092
Authors:
MCGINN CL
ROBERTSON JM
ENSMINGER WD
WALKER SC
LAWRENCE TS
Citation: Cl. Mcginn et al., A PHASE I II TRIAL OF CHEMOEMBOLIZATION WITH MITOMYCIN-C FOLLOWING HEPATIC ARTERIAL FLUORODEOXYURIDINE/LEUCOVORIN AND WHOLE LIVER RADIOTHERAPY FOR PATIENTS WITH INTRAHEPATIC MALIGNANCIES/, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 169-169
Authors:
LAWRENCE TS
TENHAKEN RK
MCGINN CJ
ENSMINGER WD
WANG S
Citation: Ts. Lawrence et al., THE TREATMENT OF INTRAHEPATIC CANCERS WITH RADIATION-DOSES BASED ON ANORMAL TISSUE COMPLICATION PROBABILITY MODEL, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 169-169
Authors:
TENHAKEN RK
BALTER JM
MARSH LH
ROBERTSON JM
LAWRENCE TS
Citation: Rk. Tenhaken et al., POTENTIAL BENEFITS OF ELIMINATING PLANNING TARGET VOLUME EXPANSIONS FOR PATIENT BREATHING IN THE TREATMENT OF LIVER-TUMORS, International journal of radiation oncology, biology, physics, 38(3), 1997, pp. 613-617
Authors:
ROBERTSON JM
LAWRENCE TS
ANDREWS JC
WALKER S
KESSLER ML
ENSMINGER WD
Citation: Jm. Robertson et al., LONG-TERM RESULTS OF HEPATIC-ARTERY FLUORODEOXYURIDINE AND CONFORMAL RADIATION-THERAPY FOR PRIMARY HEPATOBILIARY CANCERS, International journal of radiation oncology, biology, physics, 37(2), 1997, pp. 325-330
Authors:
ROBERTSON JM
ENSMINGER WD
WALKER S
LAWRENCE TS
Citation: Jm. Robertson et al., A PHASE-I TRIAL OF INTRAVENOUS BROMODEOXYURIDINE AND RADIATION-THERAPY FOR PANCREATIC-CANCER, International journal of radiation oncology, biology, physics, 37(2), 1997, pp. 331-335
Authors:
PARSELS LA
ZELLARS RC
LONEY TL
PARSELS JD
CLARKE MF
MERCHANT AK
LAWRENCE TS
MAYBAUM J
Citation: La. Parsels et al., PREVENTION OF FLUORODEOXYURIDINE-INDUCED CYTOTOXICITY AND DNA-DAMAGE IN HT29 COLON-CARCINOMA CELLS BY CONDITIONAL EXPRESSION OF WILD-TYPE P53 PHENOTYPE, Molecular pharmacology, 52(4), 1997, pp. 600-605
Authors:
WYGODA MR
WILSON MR
DAVIS MA
TROSKO JE
REHEMTULLA A
LAWRENCE TS
Citation: Mr. Wygoda et al., PROTECTION OF HERPES-SIMPLEX VIRUS THYMIDINE KINASE-TRANSDUCED CELLS FROM GANCICLOVIR-MEDIATED CYTOTOXICITY BY BYSTANDER CELLS - THE GOOD-SAMARITAN EFFECT, Cancer research, 57(9), 1997, pp. 1699-1703
Citation: Ts. Lawrence et al., FLUORODEOXYURIDINE-MEDIATED CYTOTOXICITY AND RADIOSENSITIZATION REQUIRE S-PHASE PROGRESSION, International journal of radiation biology, 70(3), 1996, pp. 273-280